Synthetic biology tools for biochemical engineering and pathway design

Introduction

Synthetic biology integrates engineering principles with molecular biology to design and construct novel biological systems with predictable behaviors [1] . The field has enabled remarkable advances in metabolic engineering through standardized genetic parts, rational design frameworks, and sophisticated genome editing tools [2] . These capabilities support development of microbial cell factories producing valuable chemicals, pharmaceuticals, and biofuels from renewable feedstocks [3] . Metabolic pathway engineering requires precise control over enzyme expression levels to optimize flux distribution and minimize accumulation of toxic intermediates [4] . Traditional approaches relying on constitutive high-expression often produce suboptimal outcomes due to metabolic burden and pathway imbalances [5] . Tunable expression systems and dynamic regulation strategies address these limitations through responsive control architectures matching enzyme levels to metabolic demands [6] . Modular genetic assembly standards including BioBricks, MoClo, and Golden Gate cloning have accelerated genetic circuit construction through standardized interfaces enabling combinatorial part assembly [7,8] . Characterized part libraries with quantified performance parameters support computational design approaches predicting circuit behavior before experimental construction [9] . Such predictability represents a fundamental advance toward engineering biology with precision comparable to established engineering disciplines [10] . CRISPR-Cas genome editing has transformed synthetic biology capabilities through efficient, programmable modification of host chromosomes [11] . Chromosomal pathway integration provides genetic stability superior to plasmid-based systems while eliminating antibiotic selection requirements [12] . Multiplexed editing enables simultaneous modification of multiple genomic loci supporting complex pathway installation [13] . This research developed comprehensive synthetic biology tools for metabolic pathway engineering in bacterial and yeast production hosts [14] . Primary objectives encompassed assembling characterized genetic part libraries, establishing efficient genome editing protocols, and demonstrating pathway optimization through systematic engineering approaches. Application to terpenoid biosynthesis validated toolkit utility for industrially relevant bioproduction targets [15] .

Theoretical Background

Metabolic flux analysis provides quantitative framework for understanding pathway behavior through measurement and modeling of intracellular reaction rates [4,5] . Flux balance analysis employing stoichiometric network models predicts optimal flux distributions under defined constraints. Dynamic flux balance analysis extends these approaches to capture time-varying metabolic states during growth and production phases [16] . Enzyme kinetic parameters including Km, kcat, and Ki determine individual reaction rates while pathway topology and enzyme concentrations establish flux control distribution [17] . Metabolic control analysis quantifies flux control coefficients identifying rate-limiting steps suitable for engineering intervention. These theoretical foundations inform rational pathway design strategies targeting highimpact modification sites [18] .

System Design

The genetic toolkit comprised hierarchical assembly levels enabling construction from basic parts through complete pathways [7,8] . Level 0 parts included promoters, ribosome binding sites, coding sequences, and terminators flanked by standardized fusion sites. Level 1 assembly combined parts into transcription units expressing single genes. Level 2 assembly joined multiple transcription units into multigene pathways on single DNA molecules [9] . Genome editing infrastructure employed Cas9 and Cas12a nucleases with species-optimized expression systems [11,12] . Guide RNA libraries targeting safe harbor integration sites were designed using established algorithms minimizing offtarget potential. Donor DNA templates included homology arms flanking pathway sequences for homology-directed repair integration [13] .

Performance Evaluation

Part characterization employed standardized measurement protocols enabling quantitative comparison across the library [9,10] . Promoter strength was quantified through fluorescent reporter expression normalized to optical density. Ribosome binding site efficiency was measured through translation initiation rate calculation from reporter assays. All measurements were performed in triplicate across three independent transformants to establish reproducibility.

Material and Methods

Strain Construction

Escherichia coli DH10B served as cloning host while BL21(DE3) and MG1655 derivatives were used for expression and pathway engineering respectively [1,2] . Saccharomyces cerevisiae CEN.PK2-1C provided the yeast chassis for eukaryotic pathway development. All strains were maintained as glycerol stocks at -80°C and verified by diagnostic PCR before experimental use.

Genetic Assembly

Modular cloning employed Type IIS restriction enzymes including BsaI and BsmBI for scarless assembly [7,8] . Golden Gate reactions combined 75 ng destination vector with equimolar part concentrations in 10 μL reactions containing T4 DNA ligase. Assembly reactions underwent 30 cycles of 37°C digestion and 16°C ligation followed by final heat inactivation.

Genome Editing

CRISPR editing utilized electrocompetent cells transformed with Cas9/gRNA plasmids and linear donor DNA [11,12] . Selection employed temperature-sensitive replicons cured through elevated temperature cultivation. Editing efficiency was calculated as the proportion of screened colonies containing desired modifications confirmed by sequencing.

Pathway Analysis

Metabolite analysis employed gas chromatography-mass spectrometry for terpenoid quantification with β-ionone as internal standard [15] . High-performance liquid chromatography with photodiode array detection quantified pathway intermediates. Enzyme activities were measured in cell-free extracts using established spectrophotometric assays.

Results

The characterized promoter library spanning 47 sequences demonstrated 340-fold dynamic range in expression strength (Table 1) [9,10] . Constitutive promoters ranged from 0.003 to 1.02 relative units normalized to reference promoter J23100. Inducible systems including IPTG, arabinose, and tetracycline-responsive promoters achieved maximum expression levels comparable to strong constitutive variants while providing stringent repression in uninduced states. CRISPR-Cas9 genome editing achieved 89.7% efficiency for single-locus modifications and 67.3% efficiency for simultaneous dual-locus editing [11][12][13] . Cas12a demonstrated superior performance for multiplexed editing with 74.8% efficiency at three simultaneous loci. Chromosomal pathway integration stability exceeded 100 generations without detectable loss in the absence of selection. Application to lycopene biosynthesis demonstrated systematic pathway optimization achieving 4.8-fold improvement over initial constructs [14,15] . Combinatorial screening of promoter-RBS combinations identified optimal expression levels for each pathway enzyme. Final optimized strain produced 47.3 ± 4.8 mg/L lycopene compared to 9.8 ± 1.7 mg/L baseline (Figure 2).

Discussion

The comprehensive genetic toolkit established through this research provides essential infrastructure for rational metabolic engineering [1][2][3] . The 340-fold expression range across characterized promoters enables precise tuning of enzyme levels to match pathway requirements. Such predictable control over gene expression represents fundamental capability for implementing computational pathway designs [9,10] . The high efficiency of CRISPR-based genome editing supports practical chromosomal pathway integration as alternative to plasmid-based expression [11,12] . Genetic stability without antibiotic selection simplifies bioprocess development and regulatory approval pathways for industrial applications. Multiplexed editing capabilities further accelerate strain construction timelines [13] . The 4.8-fold improvement in lycopene production validates toolkit utility for industrially relevant pathway optimization [14, 15] . Systematic exploration of expression space through combinatorial part assembly identified non-intuitive optimal configurations that would be difficult to predict from first principles alone. Integration of computational design with experimental validation represents effective strategy for complex pathway engineering [16][17][18] .

Conclusion

This research establishes comprehensive synthetic biology tools enabling predictable metabolic pathway engineering in microbial production hosts. Characterized genetic part libraries provide 340-fold expression range through standardized modular assembly. CRISPR genome editing achieves 89.7% efficiency for chromosomal pathway integration with excellent genetic stability. Application to terpenoid biosynthesis demonstrates 4.8-fold production improvement through systematic optimization. These tools support expanded application of rational engineering approaches to bioproduction challenges.

Acknowledgement

AcknowledgementsFunding Sources: This research was supported by CONACYT (Grant CB-2020-287634) and the UNAM PAPIIT program (Grant IN-2021-304521).Institutional Support: The authors acknowledge the UNAM Institute of Biotechnology core facilities for analytical support and the Mexican Synthetic Biology Network for collaborative resources.Contributions: C.R-V. conceived the research and supervised strain construction. M.E.G. performed genetic assembly and characterization. F.M-L. conducted genome editing and pathway integration. A.P.M. performed metabolite analysis and data interpretation. All authors contributed to manuscript preparation.

References

1. Stephanopoulos G. Synthetic biology and metabolic engineering. ACS Synthetic Biology. 2012;1(11):514525.
2. Keasling JD. Synthetic biology and the development of tools for metabolic engineering. Metabolic Engineering. 2012;14(3):189-195.
3. Nielsen J, Keasling JD. Engineering cellular metabolism. Cell. 2016;164(6):1185-1197.
4. Stephanopoulos G, Aristidou AA, Nielsen J. Metabolic engineering: principles and methodologies. San Diego: Academic Press; 1998.
5. Yadav VG, De Mey M, Lim CG, Ajikumar PK, Stephanopoulos G. The future of metabolic engineering and synthetic biology. Metabolic Engineering. 2012;14(3):233-241.
6. Xu P, Li L, Zhang F, Stephanopoulos G, Koffas M. Improving fatty acids production by engineering dynamic pathway regulation and metabolic control. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(31):1129911304.
7. Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE. 2008;3(11):e3647.
8. Weber E, Engler C, Gruetzner R, Werner S, Marillonnet S. A modular cloning system for standardized assembly of multigene constructs. PLoS ONE. 2011;6(2):e16765.
9. Canton B, Labno A, Endy D. Refinement and standardization of synthetic biological parts and devices. Nature Biotechnology. 2008;26(7):787-793.
10. Kelly JR, Rubin AJ, Davis JH, Ajo-Franklin CM, Cumbers J, et al. Measuring the activity of BioBrick promoters using an in vivo reference standard. Journal of Biological Engineering. 2009;3:4.
11. Cong L, Ran FA, Cox D, Lin S, Barretto R, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819-823.
12. Bassalo MC, Garst AD, Halweg-Edwards AL, Grau WC, Domber DW, et al. Rapid and efficient one-step metabolic pathway integration in Escherichia coli. ACS Synthetic Biology. 2016;5(7):561-568.
13. Jakočiūnas T, Bonde I, Herrgård M, Harrison SJ, Kristensen M, et al. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metabolic Engineering. 2015;28:213-222.
14. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science. 2010;330(6000):70-74.
15. Alonso-Gutierrez J, Chan R, Batth TS, Adams PD, Keasling JD, et al. Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production. Metabolic Engineering. 2013;19:33-41.
16. Mahadevan R, Edwards JS, Doyle FJ. Dynamic flux balance analysis of diauxic growth in Escherichia coli. Biophysical Journal. 2002;83(3):1331-1340.
17. Fell DA. Metabolic control analysis: a survey of its theoretical and experimental development. Biochemical Journal. 1992;286(2):313-330.
18. Kacser H, Burns JA. The control of flux. Symposia of the Society for Experimental Biology. 1973;27:65-104.
19. Lee ME, DeLoache WC, Cervantes B, Dueber JE. A highly characterized yeast toolkit for modular, multipart assembly. ACS Synthetic Biology. 2015;4(9):975-986.
20. Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nature Biotechnology. 2009;27(10):946950.
21. Smanski MJ, Bhatia S, Zhao D, Park Y, Woodruff LB, et al. Functional optimization of gene clusters by combinatorial design and assembly. Nature Biotechnology. 2014;32(12):1241-1249.